No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
273 |
Control definitions (FinnGen only)
- Control exclude
- AB1_SEXUAL_TRANSMISSION
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Trichomoniasis
based on the number of shared cases.
Similar with more cases:
- Trichomoniasis, including avohilmo
- Infections with a predominantly sexual mode of transmission
- Infections with a predominantly sexual mode of transmission, including avohilmo
- Certain infectious and parasitic diseases
- Certain infectious and parasitic diseases, including avohilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2807 | 2630 | 154 |
| Only index persons | 2299 | 2200 | 99 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.08 | 0.00 |
| Only index persons | 0.08 | 0.08 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 28.96 | 28.00 | 43.83 |
| Only index persons | 26.98 | 26.72 | 32.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 273 | 259 | 14 |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | 0.01 |
| Median age at first event (years) | 25.52 | 24.49 | 44.51 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 286
- Matched controls
- 2860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
13199
ICD-8 Finland
Trichomoniasis urogenitalis, Unspecified
+∞
251.8
203
*
13197
ICD-8 Finland
Trichomoniasis urogenitalis, Suspecta
+∞
27.5
26
*
A59.0
ICD-10 Finland
Urogenital trichomoniasis
+∞
27.5
26
*
64199
ICD-8 Finland
Abortion induced for other legal indications, Without mention of sepsis or toxaemia
4.8
26.7
72
186
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
4.7
19.8
52
130
13100, ,
ICD-8 Finland
+∞
16.8
16
*
N05CD07
ATC
temazepam; oral
3.5
16.2
66
225
11299
ICD-8 Finland
Moniliasis
40.5
15.6
19
5
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
4.7
11.2
27
62
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.5
10.3
37
115
T36
ICD-10 Finland
Poisoning by systemic antibiotics
5.4
10.0
20
39
78559
ICD-8 Finland
Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD
4.6
9.8
24
56
N05AA02
ATC
levomepromazine; systemic
5.1
9.7
21
44
09801
ICD-8 Finland
Gonococcal infections, Urethritis acuta cum salpingo-cophoritide
+∞
9.4
9
*
09808
ICD-8 Finland
Gonococcal infections, Uro-genitalis acuta, alia
+∞
9.4
9
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
9.3
71
335
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.7
9.0
30
88
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
3.5
9.0
33
104
N05AH04
ATC
quetiapine; oral
2.5
8.9
66
307
1310A
ICD-9 Finland
Trichomoniasis, Urogenital trichomoniasis
+∞
8.4
8
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.9
8.3
18
24
N07BA03
ATC
varenicline; oral
3.9
7.9
24
66
62699
ICD-8 Finland
Disorders of menstruation, Other
4.4
7.4
19
46
A59.9
ICD-10 Finland
Trichomoniasis, unspecified
+∞
7.3
7
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.8
7.3
39
153
SPAT1260
SPAT
Consultation of another employee
2.2
7.0
68
353
Z72.0
ICD-10 Finland
Tobacco use
6.4
6.9
17
28
R06.0
ICD-10 Finland
Dyspnoea
2.0
6.8
99
599
61207
ICD-8 Finland
Acute salpingitis and oophoritis, suspecta
9.0
6.6
13
15
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
6.5
146
1018
E9509
ICD-8 Finland
Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances
14.7
6.4
10
7
62200
ICD-8 Finland
Infective diseases of uterus (except cervix), vagina and vulva, Endometritis acuta
9.6
6.3
12
13
SPAT1254
SPAT
Administration of medicine
2.3
6.3
51
244
SPAT1234
SPAT
Support of social functional capacity
3.6
6.3
21
62
61208
ICD-8 Finland
Acute salpingitis and oophoritis, Alia definita
8.9
6.1
12
14
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
6.0
37
156
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
129
2.95
7.34
3.9
3.1
2.11
1.75
mmol/l
0.24
27
101
84
478
2.07
6.81
2.1
1.7
1120.61
1266.73
nmol/l
0.72
52
350
160
2033
0.52
6.81
27.9
21.4
330.08
330.03
g/l
0.02
160
2023
72
392
2.12
6.53
5.6
5.2
32.29
33.62
%
0.49
45
234
191
1480
1.87
5.79
8.5
6.1
1.22
1.22
mmol/l
0.25
145
1263
177
1344
1.83
5.68
6.5
5.5
1.22
1.22
mmol/l
0.09
151
1223
196
1579
1.77
4.71
6.8
4.6
6.78
6.58
mmol/l
0.75
184
1494
65
382
1.91
4.65
2.9
2.2
21.28
21.60
%
0.06
56
355
124
890
1.69
4.49
3.2
2.4
49.13
63.11
u/l
1.75
113
794
163
1275
1.65
4.12
13.0
11.8
1.12
1.18
inr
0.97
143
1025
140
1056
1.64
4.07
5.5
3.7
42.12
112.38
ng/l
0.60
107
781
116
840
1.64
3.94
4.8
4.5
0.00
0.00
estimate
-0.00
45
276
68
426
1.78
3.93
3.1
2.3
11.36
12.71
umol/l
0.96
60
394
122
900
1.62
3.82
3.2
2.8
2051.92
983.58
ng/l
1.01
96
766
196
1632
1.64
3.64
4.6
3.1
53.13
47.80
u/l
0.41
174
1495
64
404
1.75
3.58
3.1
2.2
2.18
2.37
g/l
1.52
56
370
185
1522
1.61
3.58
6.8
6.3
9.15
10.05
umol/l
1.29
171
1430
22
94
2.45
3.51
3.3
1.9
—
—
—
0
0
21
88
2.50
3.48
3.3
1.9
—
—
—
0
0
49
290
1.83
3.39
5.7
3.5
—
—
—
0
0
20
84
2.48
3.31
3.1
2.4
—
—
—
0
0
67
439
1.69
3.27
2.1
1.9
—
—
—
0
0
9
20
4.61
3.14
1.6
1.4
14.87
16.97
ug/l
—
9
20
111
832
1.55
3.10
2.2
1.7
19.43
21.86
nmol/l
0.79
87
685
30
157
2.02
2.98
3.8
3.2
4.02
4.48
pmol/l
1.88
30
135
14
52
2.78
2.93
2.9
1.7
—
—
—
0
0
157
1278
1.51
2.93
5.2
4.1
34.25
35.81
g/l
2.67
138
1201
98
726
1.53
2.84
5.3
3.8
0.00
0.00
estimate
-0.00
35
234
13
48
2.79
2.75
1.5
1.3
—
—
—
0
0
43
261
1.76
2.74
3.0
2.0
0.19
0.21
g/l
0.84
36
246
18
82
2.28
2.53
5.9
2.6
26.70
25.37
mmol/l
0.69
18
82
81
589
1.52
2.52
1.8
1.8
446.45
13588582.86
pmol/l
0.50
60
471
181
1543
1.47
2.52
8.7
10.0
4.36
3.85
e9/l
1.99
157
1347
22
110
2.08
2.48
3.0
1.4
—
—
—
0
0
11
41
2.75
2.23
3.1
1.5
—
—
—
0
0
13
54
2.47
2.23
6.5
2.9
7.29
7.91
kpa
0.78
13
54
9
30
3.06
2.16
1.1
1.2
50.67
53.00
u/l
—
9
25
5
10
5.07
2.08
1.8
2.4
42.64
42.98
g/l
—
5
10
12
50
2.46
2.05
3.3
2.7
16.16
16.14
%
0.01
12
50
88
680
1.42
1.97
1.3
1.3
0.82
1.45
u/ml
0.81
25
172
115
934
1.39
1.93
4.0
3.4
—
—
—
0
0
38
247
1.62
1.91
4.3
3.6
1.24
1.23
mmol/l
0.10
27
209
14
65
2.21
1.91
1.1
1.6
—
—
—
0
0
37
239
1.63
1.91
1.7
1.5
—
—
—
0
0
19
100
1.96
1.90
2.8
1.3
—
—
—
0
0
7
22
3.23
1.89
1.1
1.2
—
—
—
0
0
6
17
3.58
1.84
1.0
1.2
—
—
—
0
0
6
17
3.58
1.84
1.0
1.2
—
—
—
0
0
37
243
1.60
1.79
3.1
2.9
68.30
74.44
ng/l
0.23
30
211
86
675
1.39
1.74
3.5
2.2
2.90
3.02
mg/l
0.25
70
572
139
1181
1.34
1.70
4.1
3.0
130.37
103.84
ug/l
0.97
119
1082
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
12
56
2.19
1.63
3.2
2.4
0.34
0.45
iu/ml
—
7
34
170
1495
1.34
1.62
4.9
4.3
0.00
0.00
estimate
-0.00
43
278
228
2100
1.42
1.60
9.9
8.2
82.49
79.01
u/l
0.43
211
1955
147
1271
1.32
1.55
2.5
2.1
113.51
99.43
pmol/l
1.71
71
569
167
1474
1.32
1.50
4.9
4.3
0.00
6.34
estimate
0.50
48
296
14
251
0.54
1.49
3.4
2.7
67.75
65.17
ml/min/173m2
—
8
103
5
16
3.16
1.44
1.4
1.6
—
—
—
0
0
145
1267
1.29
1.35
3.1
2.6
—
—
estimate
—
0
0
10
47
2.17
1.35
1.2
1.4
—
—
—
0
0
90
738
1.32
1.35
3.6
3.4
0.57
0.44
e6/l
0.22
69
524
17
98
1.78
1.34
1.3
4.3
123.34
35.37
mg/l
0.47
12
81
17
98
1.78
1.34
1.3
4.3
27.57
27.54
mg/l
0.00
12
81
21
129
1.68
1.34
1.3
1.4
—
—
—
0
0
43
575
0.70
1.32
1.6
1.4
—
—
—
0
0
9
43
2.13
1.31
1.1
1.3
—
—
—
0
0
9
43
2.13
1.31
1.1
1.3
—
—
—
0
0
9
43
2.13
1.31
1.1
1.3
—
—
—
0
0
5
18
2.81
1.29
1.0
1.3
—
—
—
0
0
219
2031
1.33
1.26
5.5
4.9
16.85
13.55
mm/h
2.11
193
1861
83
680
1.31
1.24
2.6
2.3
—
—
—
0
0
8
38
2.14
1.19
1.1
1.0
—
—
—
0
0
116
999
1.27
1.18
4.6
3.9
11.82
5.52
mg/mmol
0.73
60
537
123
1068
1.27
1.16
4.9
4.2
0.00
0.00
estimate
0.50
33
229
8
39
2.08
1.16
1.1
1.4
—
—
—
0
0
163
1465
1.26
1.14
4.9
4.2
0.00
0.00
estimate
-0.00
46
287
7
30
2.37
1.13
1.1
1.0
—
—
—
0
0
8
40
2.03
1.13
1.1
1.4
—
—
—
0
0
8
40
2.03
1.13
1.1
1.4
—
—
—
0
0
13
73
1.82
1.13
1.2
1.6
—
—
—
0
0
104
892
1.26
1.08
2.3
2.2
141.55
157.79
u/l
0.22
91
846
14
83
1.72
1.03
1.1
1.3
—
—
—
0
0
76
632
1.28
1.01
1.6
1.6
0.90
1.17
mg/l
0.72
60
499
44
340
1.35
0.98
2.9
4.4
15.25
7.80
ug/l
0.43
35
286
46
358
1.34
0.98
4.8
6.0
—
—
—
0
0
16
101
1.62
0.95
1.1
1.4
—
—
—
0
0
152
1374
1.23
0.95
3.0
2.5
78.05
80.28
nmol/l
0.47
129
1217
7
37
1.91
0.94
4.3
5.4
12.10
13.12
mg/l
—
7
32
101
881
1.23
0.88
3.7
3.0
30.47
29.41
u/l
0.15
85
819
26
188
1.42
0.86
1.5
1.3
312.43
251.10
u/ml
0.11
19
179
230
2183
1.27
0.86
6.0
4.9
14.99
15.01
pmol/l
0.05
195
1988
12
72
1.70
0.86
3.3
1.5
—
—
—
0
0
14
88
1.62
0.86
1.4
4.1
1.09
2.02
ratio
—
7
50
15
97
1.58
0.83
2.0
1.7
1.08
1.22
g/l
0.81
15
92
14
90
1.58
0.79
1.2
1.2
—
—
—
0
0
9
55
1.66
0.74
1.3
1.3
—
—
—
0
0
9
56
1.63
0.73
1.1
1.3
—
—
—
0
0
5
25
2.02
0.73
1.8
2.3
—
—
—
0
0
5
26
1.94
0.71
1.6
2.4
1.00
3.14
nmol/l
—
5
26
5
26
1.94
0.71
1.0
1.0
—
—
—
0
0
18
128
1.43
0.67
1.8
1.6
11.09
7.18
iu/ml
—
7
31
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
5
28
1.80
0.66
1.4
1.2
—
—
—
0
0
14
95
1.50
0.65
1.1
1.3
—
—
—
0
0
5
29
1.74
0.64
2.6
3.8
—
—
—
0
0
15
104
1.47
0.64
2.5
1.4
224.70
264.45
ug/g
—
10
62
41
336
1.26
0.63
1.8
1.8
—
—
—
0
0
8
52
1.55
0.60
1.3
1.4
—
—
—
0
0
6
35
1.73
0.58
1.7
1.4
4.42
113.02
u/ml
—
6
35
9
61
1.49
0.54
1.2
1.5
—
—
—
0
0
259
2525
1.27
0.53
22.9
15.6
23.79
21.60
mg/l
0.51
226
2058
21
161
1.33
0.53
2.0
1.7
—
—
—
0
0
12
83
1.47
0.52
2.3
2.0
10.10
11.65
mg/l
0.42
12
78
75
668
1.17
0.51
2.5
2.6
335.72
323.26
umol/l
0.48
61
566
35
291
1.23
0.49
4.6
2.4
4.59
6.60
umol/l
1.28
27
254
12
85
1.43
0.47
1.1
1.3
—
—
—
0
0
255
2488
1.23
0.47
8.1
6.9
40.29
39.40
mmol/mol
0.99
221
2302
7
49
1.44
0.46
1.3
1.7
—
—
—
0
0
262
2565
1.26
0.45
6.4
5.7
6.07
5.94
mmol/l
0.90
221
2324
144
1353
1.13
0.45
2.8
2.5
—
—
—
0
0
22
273
0.79
0.45
3.5
2.3
35.71
36.22
u/l
0.03
17
223
6
91
0.65
0.43
1.2
1.2
—
—
—
0
0
6
91
0.65
0.43
1.3
4.1
28.83
25.09
u/ml
—
6
91
8
56
1.44
0.43
1.1
1.1
—
—
—
0
0
5
33
1.52
0.41
1.2
1.8
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
2.74
—
0
10
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
1.24
—
0
10
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
9
67
1.35
0.38
1.7
1.7
—
—
—
0
0
9
69
1.31
0.37
2.9
2.5
6.07
6.99
pmol/l
—
9
69
132
1246
1.11
0.36
1.9
2.0
1.36
1.31
mmol/l
0.33
91
1014
6
42
1.44
0.36
1.0
1.1
—
—
—
0
0
6
42
1.44
0.36
1.3
1.1
11.98
40.45
u/l
—
6
33
23
191
1.22
0.34
1.2
1.2
95.67
130.90
u/ml
—
10
78
6
90
0.66
0.33
1.2
1.2
—
—
—
0
0
24
204
1.19
0.29
1.6
1.5
—
—
—
0
0
269
2656
1.22
0.28
26.2
18.6
139.43
139.86
mmol/l
1.71
257
2592
10
128
0.77
0.27
1.7
1.4
—
—
—
0
0
5
71
0.70
0.26
1.6
1.3
—
—
—
0
0
9
76
1.19
0.25
1.7
1.6
—
—
—
0
0
269
2659
1.20
0.24
26.5
18.7
3.97
3.95
mmol/l
0.34
257
2585
5
39
1.29
0.23
1.4
1.7
—
—
—
0
0
112
1070
1.08
0.22
2.7
3.6
2.36
2.37
mmol/l
0.28
97
973
5
41
1.22
0.22
1.4
1.4
—
—
—
0
0
251
2474
1.12
0.21
7.8
6.2
1.90
1.93
mu/l
0.09
216
2262
0
11
0.00
0.21
0.0
1.0
—
1673.73
—
0
11
0
11
0.00
0.21
0.0
1.4
—
47.03
—
0
11
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
39.10
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
9.63
—
0
10
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
10
80
1.26
0.20
4.9
3.0
1.89
1.44
mg/l
—
10
68
43
467
0.91
0.20
3.4
2.9
1.63
1.15
e6/l
0.39
24
242
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
38
414
0.91
0.19
3.5
3.1
4.78
4.24
e6/l
0.13
18
187
48
515
0.92
0.18
5.5
4.0
54.85
174.33
ng/l
1.51
34
409
5
66
0.75
0.17
1.2
1.1
2.84
3.95
mmol/l
—
5
61
5
67
0.74
0.17
1.2
1.2
21977.80
76.87
e6/l
—
5
53
6
76
0.79
0.16
1.2
1.2
512.00
498.54
mg/l
—
6
71
10
119
0.83
0.15
1.3
1.6
—
—
—
0
0
20
178
1.13
0.15
5.1
3.3
359.20
164.04
ng/l
0.80
20
167
56
592
0.93
0.15
1.4
1.3
33.85
31.83
iu/ml
0.05
13
185
253
2506
1.08
0.12
21.2
15.9
78.75
77.14
ml/min/173m2
0.66
228
2328
14
124
1.14
0.11
1.6
1.3
—
—
—
0
0
258
2559
1.08
0.11
5.9
5.6
4.73
4.82
mmol/l
0.75
223
2338
17
154
1.11
0.10
1.0
1.0
—
—
—
0
0
62
644
0.95
0.10
2.5
2.7
2.50
2.46
mmol/l
1.37
55
589
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
6
54
1.11
0.09
1.3
1.5
—
—
—
0
0
33
315
1.05
0.06
2.0
1.9
—
—
—
0
0
66
646
1.03
0.04
4.0
4.4
1.01
1.02
kg/l
1.10
42
428
269
2680
1.06
0.04
15.3
13.1
23.30
23.44
u/l
0.07
253
2584
244
2431
1.03
0.02
5.0
4.6
1.35
1.26
mmol/l
1.22
201
2191
273
2723
1.06
0.01
33.8
24.6
265.04
258.90
e9/l
0.72
260
2664
41
417
0.98
0.01
1.6
1.4
—
—
—
0
0
273
2724
1.05
0.00
33.9
24.8
129.00
131.95
g/l
3.08
263
2690
273
2724
1.05
0.00
34.0
24.9
38.93
39.70
%
2.00
263
2688
273
2724
1.05
0.00
33.7
24.5
4.29
4.39
e12/l
3.13
260
2651
270
2694
1.04
0.00
29.1
21.4
71.56
70.66
umol/l
0.16
262
2651
260
2601
1.00
0.00
6.8
6.6
2.62
2.75
mmol/l
1.52
226
2367
272
2723
0.98
0.00
33.8
24.5
91.56
91.44
fl
0.15
262
2687
254
2543
0.99
0.00
6.2
5.5
1.55
1.62
mmol/l
1.50
218
2313
56
557
1.01
0.00
1.2
1.3
14.43
12.44
u/ml
0.06
16
210
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
2.06
—
0
5
0
7
0.00
0.00
0.0
1.3
—
158.71
—
0
7
0
5
0.00
0.00
0.0
1.4
—
12.20
—
0
5
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
5.86
—
0
5
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
75
0.93
-0.00
1.7
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.3
—
200.44
—
0
9
0
6
0.00
-0.00
0.0
2.2
—
4.49
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
108.33
—
0
6
0
9
0.00
-0.00
0.0
1.4
—
275.30
—
0
9
0
6
0.00
-0.00
0.0
2.2
—
10.60
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_TRICHOMONIASIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_TRICHOMONIASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_TRICHOMONIASIS – Trichomoniasis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data